CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-24 | Flynn James E 10% owner | Sale | −50,177 | $4.52 | $227K | 3,792,168 |
| 2019-06-21 | Flynn James E 10% owner | Sale | −70,135 | $4.62 | $324K | 1,096,824 |
| 2019-06-21 | Flynn James E 10% owner | Sale | −269,402 | $4.62 | $1.2M | 3,842,345 |
| 2019-06-06 | Mehra Anand Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-06-06 | Humphries William D. Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-06-06 | Molineaux Christopher P. Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-06-06 | Powell Andrew Kenneth William Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-06-06 | Reasons Bryan M. Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-06-06 | SCHIFF ANDREW N Director | Grant or award · Restricted Stock Units | +7,333 | 7,333 | ||
| 2019-05-10 | Flynn James E 10% owner | Sale | −108,696 | $6.05 | $658K | 4,111,747 |
| 2019-05-10 | Flynn James E 10% owner | Sale | −71,869 | $6.05 | $435K | 1,166,959 |
| 2019-05-09 | Flynn James E 10% owner | Sale | −261,345 | $6.16 | $1.6M | 4,220,443 |
| 2019-05-09 | Flynn James E 10% owner | Sale | −172,800 | $6.16 | $1.1M | 1,238,828 |
| 2019-03-01 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Restricted stock units | +68,700 | 68,700 | ||
| 2019-03-01 | Walker Neal President and CEO | Grant or award · Restricted stock units | +384,600 | 384,600 | ||
| 2019-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +103,000 | 103,000 | ||
| 2019-03-01 | Gordon David N. Chief Medical Officer | Grant or award · Restricted stock units | +82,400 | 82,400 | ||
| 2019-03-01 | Shanler Stuart Chief Scientific Officer | Grant or award · Restricted stock units | +82,200 | 82,200 | ||
| 2019-02-01 | Walker Neal President and CEO | Option exercise | +10,800 | 920,924 | ||
| 2019-02-01 | Walker Neal President and CEO | Shares withheld for taxes | −3,579 | $6.96 | $25K | 917,345 |
Page 41 of 47 · 928 trades